Amniotic membrane therapy is an advanced, in-office treatment option for patients with moderate to severe dry eye disease—especially when traditional therapies have not provided adequate relief. Amniotic membranes are biologic tissue grafts derived from donated human placental tissue that are processed and sterilized for safe medical use.
These membranes contain naturally occurring growth factors, anti-inflammatory proteins, and healing components that help support the regeneration of the ocular surface. When placed on the eye, they act as a protective, soothing layer that can:
Reduce inflammation and irritation
Promote healing of the corneal and conjunctival surface
Improve tear film quality and comfort
Support recovery in cases of significant surface damage or persistent dry eye symptoms
During a brief in-office visit, the clinician places the therapeutic amniotic membrane on the affected ocular surface. The membrane adheres comfortably and works beneath the natural tear film to promote healing. Over time, the membrane naturally dissolves or is gently removed, leaving behind a calmer, healthier surface.
Amniotic membrane therapy is especially beneficial for patients with recalcitrant dry eye, ocular surface inflammation, or corneal epithelial defects. It can be used as part of a comprehensive dry eye care plan that includes other treatments like eyelid hygiene, tear supplements, and advanced therapies.